Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LC Drug Eluting Bead for Downstaging HCC
NCT00877071Phase 2Completed
- Sponsor
- University of Pittsburgh
- Start
- Nov 2008
- Primary completion
- May 2011
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of doxorubicin in hepatocellular carcinoma (HCC), sponsored by University of Pittsburgh. Started Nov 2008; status: completed.
02
Drugs
doxorubicin
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00877071.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00877071.